- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
NRC Health(NRC)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NRC
11/13/2026: NRC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
NRC Health is a healthcare technology and analytics company that provides specialized subscription platforms to help hospitals measure patient, consumer, and employee experiences. The company's primary strengths lie in its deep domain heritage, sticky enterprise relationships, and robust proprietary benchmark databases. Its core growth opportunity centers on deploying advanced AI-driven tools and expanding into outpatient care settings. However, the business faces notable risks from hospital budgetary pressures and intense competition from larger market players. The stock suits dividend-focused investors seeking steady income paired with exposure to healthcare technology, though ongoing execution in AI product adoption should be closely monitored.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Top-line revenue growth has been modest, though emerging tech initiatives offer moderate expansion angles. |
| Momentum investor | Strong fit while signal remains positive | Momentum fit is conditional on a positive upturn signal and near-term technical strength. |
| Value investor | Mixed fit | Valuation metrics are supported by consistent cash generation, offset by recent earnings variability. |
| Dividend investor | Strong fit | The company has a consistent history of returning significant portions of earnings via regular dividend payouts. |
| Low-risk investor | Mixed fit | While customer retention is strong, enterprise sales exposure and leverage keep risk at a moderate level. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The stock experiences standard periodic fluctuations dictated by small-cap healthcare tech liquidity. |
| Valuation risk | Medium | Valuation can fluctuate depending on shifts in annual net income and broader market multiples. |
| Competition risk (Press Ganey & tech suites) | Medium / high | Intense rivalry from larger market research firms and enterprise software platforms threatens client retention. |
| Business quality | Strong | NRC Health benefits from entrenched client relationships and recurring subscription models across top hospitals. |
| Dividend income | Medium / high | The firm consistently allocates capital to dividends, though payout ratios relative to net income can vary. |
| Execution risk | Medium | Successful commercialization of new AI and digital tools is vital for sustaining long-term competitiveness. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 563.64M USD | Price to earnings Ratio 98.37 | 1Y Target Price 27 |
Price to earnings Ratio 98.37 | 1Y Target Price 27 | ||
Volume (30-day avg) 103.7K shares | Beta 0.24 | 52 Weeks Range 11.45 - 27.60 | Updated Date 11/15/2026 |
52 Weeks Range 11.45 - 27.60 | Updated Date 11/15/2026 | ||
Dividends yield (FY) 2.40% | Basic EPS (TTM) 0.27 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Health Information Services
- BUY participation
- 100.0%
- Active BUY / eligible
- 4 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -2.93% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Subscription & SaaS Solutions | Recurring software fees for patient experience tracking, digital surveys, and analytics platforms. | This provides the company with predictable, sticky recurring revenues from major health systems. |
| Improvement Consulting & Professional Services | Advisory services, specialized reporting, and custom market research programs. | Deepens client integration and helps health systems interpret complex experience data. |
| Geographic Exposure (United States & Canada) | Primary operations concentrated in North American healthcare provider networks. | Exposes the business directly to trends and budgetary cycles within North American healthcare. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-27 | When After Market | Estimate 0.21 | Actual 0.21 |
Profitability
Profit Margin 4.48% | Operating Margin (TTM) 13.36% |
Management Effectiveness
Return on Assets (TTM) 8.74% | Return on Equity (TTM) 248.11% |
Valuation
Trailing PE 98.37 | Forward PE 17.21 | Enterprise Value 662.92M | Price to Sales(TTM) 3.92 |
Enterprise Value 662.92M | Price to Sales(TTM) 3.92 | ||
Enterprise Value to Revenue 4.61 | Enterprise Value to EBITDA 27.07 | Shares Outstanding 21.22M | Shares Floating 11.06M |
Shares Outstanding 21.22M | Shares Floating 11.06M | ||
Percent Insiders 51.33 | Percent Institutions 52.1 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

